What We're Reading: Page 249
Industry reads hand-picked by our editors
Dec 04, 2018
-
STAT
Justice Departments tells Supreme Court it wants to scuttle case against Gilead
-
The Hill
Chinese scientist who claimed gene-editing success now missing: report
-
The New York Times
Giving Patients a Voice in Their Mental Health Care Before They’re Too Ill to Have a Say
-
NPR
Before Starting A Statin, Talk It Over With Your Doctor
Dec 03, 2018
Nov 30, 2018
-
Business Insider
Novartis CEO said he was 'completely blindsided' by Michael Cohen contract
-
Financial Times
Nimble biotechs become vital partners for large pharma groups
-
STAT
An FDA approval could come at a major cost for patients
-
The Wall Street Journal
Biotech looks ready for its deal test
Nov 29, 2018
Nov 28, 2018
-
Kaiser Health News
Chronically ill, traumatically billed: The $123,000 medicine for MS
-
Reuters
Medicine or vice? Socially screened funds struggle to define cannabis industry
-
The Wall Street Journal
Big tech expands footprint in health
Nov 27, 2018
Nov 26, 2018
-
Reuters
U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million
-
The New York Times
This City’s Overdose Deaths Have Plunged. Can Others Learn From It?
-
The Wall Street Journal
Pharma Stocks Soothe Stock-Market Malady
Previous
